Health Insurance Cancer Survivor Rules Under IRDAI 2024

Personal Finance · Health Insurance · Quick answer 45 sec · Full read 12 min

Health insurance cancer survivor rules: can an insurer refuse cover under IRDAI 2024?

No — the 2024 circular explicitly requires insurers to offer a policy to applicants with severe pre-existing conditions, including cancer survivors. The IRDAI health insurance rules overview covers the moratorium and waiting-period framework in general; this article covers what happens specifically at the point of application for a cancer survivor applying for a new policy.

Before the 2024 circular, insurers could and did decline to underwrite applicants with a cancer history. The circular changed this: the insurer must issue a policy. The regulator’s position is that access to coverage is a right, not a discretion of the underwriting desk.

What the insurer retains the right to do — and this matters practically:

Loading (higher premium). The insurer can price the policy above the standard premium to reflect the elevated risk. There is no regulatory cap on loading quantum under the 2024 circular, though the amount must be disclosed in the offer in writing. Life insurers apply the same underwriting logic to a cancer history, and the treatment there is different again — see how term insurance underwriting handles declared medical history.

Waiting period on cancer-related claims. A waiting period of up to 36 months may be applied to claims arising from the cancer history. During this period, the insurer pays claims for unrelated conditions but not for cancer or its direct complications. After 36 months of continuous coverage, the waiting period lapses and cancer claims are eligible.

Permanent exclusion of cancer as a covered condition. The insurer can offer a policy that permanently excludes cancer-related claims. Such a policy covers everything else — cardiac events, accidents, other illnesses — but will never cover cancer. This is the worst outcome for a cancer survivor and can sometimes be negotiated at application or countered by choosing a different insurer.

The insurer must provide written reasons for whichever of these tools it uses, within 15 days of the underwriting decision. If no written reason is provided within that window, the decision is not enforceable.

Permanent exclusion versus waiting period: what to ask for

A waiting period is almost always preferable to a permanent exclusion — push back on any offer that comes with permanent cancer exclusion if you are applying as a cancer survivor in remission.

The difference in outcome is total. A policy with a 36-month waiting period on cancer provides full coverage for cancer-related claims from month 37 onwards. A policy with a permanent exclusion of cancer never pays a cancer-related claim, regardless of how long you hold the policy or how consistently you have paid premiums. For a survivor in long-term remission, the permanent exclusion policy carries the word “health insurance” on the certificate but provides no protection against the condition with the highest probability of recurring.

How to identify which you have been offered: look for the word “permanent exclusion” or “specific exclusion” in the Customer Information Sheet (CIS) that the insurer must provide before you sign. The CIS must list exclusions in plain language. If the exclusion is listed as applying “for the duration of the policy” or “permanently,” it is a permanent exclusion. If it lists a number of months after which it lapses, it is a waiting period.

Read the rest of the same document while you are in it. An exclusion is the blunt instrument, but a sub-limit caps what the policy pays without excluding anything at all — the mechanism at work in the robotic surgery sub-limit rules, where coverage is mandatory but the payout ceiling is not. A cancer policy can carry both: cancer covered after 36 months, and a modern-treatment cap on how much of the treatment cost is actually paid.

If the first insurer offers only a permanent exclusion on cancer, you can apply to other insurers. Underwriting decisions vary across companies — what one insurer permanently excludes another may accept with a waiting period and a loading. Comparing two or three offers before accepting a permanent exclusion is worth the time.

IRDAI mandates that the insurer cannot deny renewal of an existing policy because a claim was made in a prior year. If you already hold a health policy and develop cancer during coverage, the insurer cannot drop you at the next renewal — this protection is separate from the application-stage rules above.

Disclosure, the moratorium, and what happens at 60 months

Disclose your cancer history honestly at application — the moratorium does not protect fraud, and an undisclosed cancer history remains a valid rejection ground for 60 months from policy inception.

The 60-month moratorium in the IRDAI 2024 circular works as follows: once a policy has been renewed without a break for 60 months of continuous coverage, the insurer cannot repudiate a claim on grounds of non-disclosure or misrepresentation of pre-existing conditions. This matters for borderline PED cases — conditions a policyholder was unaware of at the time of application, or conditions whose materiality was genuinely disputed.

For cancer survivors, the moratorium has a specific interaction. If you disclose your cancer history at application, the insurer prices the risk through loading, a waiting period, or an exclusion, and your coverage is unambiguous from day one. If you do not disclose, the insurer retains the right to repudiate any claim on non-disclosure grounds for the full 60 months. After 60 months, that specific ground lapses — but established fraud survives the moratorium. A deliberate concealment of a known cancer history that the insurer can document as intentional is not protected by the 60-month clock.

The practical conclusion: for a cancer survivor, disclosure is the better strategy. A waiting period policy, honestly underwritten, gives you 36 months of non-cancer coverage and then full coverage after that. An undisclosed policy gives you 60 months of repudiation risk and permanent uncertainty. The moratorium was designed to protect policyholders with innocent non-disclosures; it does not shelter intentional concealment of a condition as significant as a cancer history.

After the underwriting decision: what to check in the issued policy

When checking your documentation after the underwriting decision: confirm that the CIS lists your cancer history as a declared pre-existing disease, that the waiting period or exclusion terms match what was discussed, and that no additional exclusions were added without your awareness. Under IRDAI’s grievance framework, a mismatch between the verbal offer and the issued policy is a grievable matter — and the same principle, that the document governs and the sales conversation does not, is what the RBI rules on mis-selling and bundling enforce on the banking side.

One planning point that survives a loading or an exclusion: the premium remains deductible under Section 80D of the Income-tax Act, 1961 (Section 126 of the Income-tax Act, 2025), and the deduction attaches to the premium paid, not to what the policy eventually pays out — so a loaded premium is deductible in full up to the applicable limit. The limits are set out in our income tax guide for salaried filers. A loading also raises the cost of the cover permanently, which is a reason to size the base policy deliberately rather than by habit — see how to size health cover for a salaried household.